(Q37154879)

18 August 2017

1 reference

title

Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons (English)

1 reference

antiphospholipid syndrome

18 August 2017

main subject

1 reference

Eyal Muscal

1

1 reference

18 August 2017

Robin L Brey

series ordinal

2

1 reference

18 August 2017

publication date

1 January 2008

1 reference

Current Rheumatology Reports

18 August 2017

published in

1 reference

18 August 2017

volume

10

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

67-73

1 reference

Predictors of cognitive dysfunction in patients with systemic lupus erythematosus

18 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-008-0012-Y

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-008-0012-Y

Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-008-0012-Y

Antiphospholipid antibodies bind to rat cerebellar granule cells: the role of N-methyl-D-aspartate receptors

21 January 2018

1 reference

12 December 2020

Management of antiphospholipid antibody syndrome: a systematic review

1 reference

12 December 2020

Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies

1 reference

12 December 2020

High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia

1 reference

12 December 2020

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

1 reference

12 December 2020

Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke

1 reference

12 December 2020

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

1 reference

12 December 2020

Treatment of the antiphospholipid syndrome

1 reference

12 December 2020

Managing antiphospholipid antibodies and antiphospholipid syndrome in children

1 reference

12 December 2020

Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis

1 reference

12 December 2020

The antiphospholipid syndrome

1 reference

12 December 2020

The blood-brain barrier in systemic lupus erythematosus

1 reference

12 December 2020

Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

1 reference

12 December 2020

Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells

1 reference

12 December 2020

Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome

1 reference

12 December 2020

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome

1 reference

12 December 2020

Cerebral haemostasis and antiphospholipid antibodies

1 reference

12 December 2020

Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome

1 reference

12 December 2020

Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes

1 reference

12 December 2020

Antiphospholipid syndrome and recurrent thrombosis in children

1 reference

12 December 2020

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

12 December 2020

Antiphospholipid syndrome: an overview.

1 reference

12 December 2020

Neuropsychological deficits associated with antiphospholipid antibodies

1 reference

12 December 2020

Risk factors for recurrent thrombosis: prospective study of a cohort of Japanese systemic lupus erythematosus

1 reference

12 December 2020

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model

1 reference

12 December 2020

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

1 reference

12 December 2020

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

1 reference

12 December 2020

Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms

1 reference

12 December 2020

A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus

1 reference

12 December 2020

Endothelium and the brain in CNS lupus

1 reference

12 December 2020

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

1 reference

12 December 2020

Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

1 reference

12 December 2020

beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome

1 reference

12 December 2020

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals

1 reference

12 December 2020

Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement

1 reference

12 December 2020

Management of the neurological manifestations of APS--what do the trials tell us?

1 reference

12 December 2020

Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies

1 reference

12 December 2020

New approaches to prevention of thrombosis in the antiphospholipid syndrome: Hopes, trials, and tribulations

1 reference

12 December 2020

Central nervous system involvement in the antiphospholipid (Hughes) syndrome

1 reference

12 December 2020

Diagnosis of antiphospholipid syndrome

1 reference

12 December 2020

Prophylaxis of the antiphospholipid syndrome: a consensus report

1 reference

12 December 2020

Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study

1 reference

12 December 2020

10.1007/S11926-008-0012-Y

Identifiers

DOI

1 reference

18 August 2017

1 reference